Blood Test Could Predict the Best Type of Treatment for Metastatic Melanoma

A new study finds that people with lower levels of tumor DNA in their blood stream may be better candidates for immune checkpoint inhibitors as a first treatment.

Determining Treatment for Metastatic Melanoma

A blood test or “liquid biopsy” can pick up bits of tumor DNA in your bloodstream.
Lower levels of circulating tumor DNA could mean you’ll have a better response to immune checkpoint inhibitors for metastatic melanoma.
Use of liquid biopsy is increasing across all phases of cancer screening, diagnosis and treatment.